Intragastric Balloon Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The report covers Intragastric Balloons Market Manufacturers and the market is Segmented by Type (Single, Dual, and Triple), Filling Material (Gas Filled and Saline Filled), End User (Hospitals, Ambulatory Surgery Centers, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Intragastric Balloon Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Intragastric Balloon Market Size

Intragastric Balloon Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
CAGR 9.10 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration High

Major Players

Intragastric Balloon Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Intragastric Balloon Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Intragastric Balloon Market Analysis

The Intragastric Balloon Market is expected to register a CAGR of 9.1% during the forecast period.

  • The outbreak of the COVID-19 pandemic impacted the intragastric balloon market. People with an underlying condition such as obesity were at greater risk during the COVID-19 pandemic. For instance, as per the data published by the World Health Organization (WHO), in 2020, more than 1.9 billion adults, 18 years and older, were overweight. Among them, over 650.0 million were obese. Similarly, as per the data published by the CDC in March 2021, around 30.2% of the total COVID-19 hospitalizations were attributed to obesity. In addition, during COVID-19, the obesity rate increased exponentially. 
  • For instance, according to the research article published by the European Journal of Nutrition in December 2021, the rate of obesity increased during the pandemic due to a change in lifestyle and a decrease in exercise practice among people, as they avoided gym and yoga classes due to the social distancing protocols. Thus, such an increased rate of obesity surged the demand for intragastric balloons during the pandemic, and thus, the market witnessed positive growth during COVID-19 and is expected to continue the upward trend over the forecast period.
  • The rising adoption of minimally invasive treatment and the increasing prevalence of obesity are the major factors propelling market growth. For instance, according to the report published by the World Health Organization (WHO) in March 2022, more than 1.0 billion people worldwide are obese, of which 650 million adults, 340 million adolescents, and 39 million children. The same source also stated that by 2025, approximately 167 million people will be obese, including adults and children. Intragastric balloons are widely used for the treatment of obesity and offer effective results. 
  • For instance, according to the National Center for Biotechnology Information (NCBI) study published in January 2023, intragastric balloons serve as a minimally invasive tool to combat the obesity pandemic. There are multiple intragastric balloons approved for the United States and European markets. Indications in the United States include a BMI of 30 to 35 kg/m^2 but a BMI of 27 to 35 kg/m^2 in Europe. Thus, increasing cases of obesity across the globe are expected to positively impact market growth.
  • The increasing preference towards minimally invasive treatment and product launches by the key players are also driving market growth. For instance, according to the NCBI research article published in February 2022, in the studied population, about 57.0% of the patients who preferred minimally invasive treatment made their decision under the influence of the healthcare professionals as they recommended minimally invasive treatment and reported less perceived disadvantages following their treatment. Such studies depict the higher acceptance of healthcare professionals and patients of minimally invasive procedures over traditional procedures. Furthermore, in September 2022, Allurion Technologies, the United States-based medical device manufacturer, launched its weight loss solution, a swallowable gastric balloon, in India. The product claims to reduce weight by 10-15% on average within 16 weeks. Therefore, increasing adoption of minimally invasive treatments and product launches are anticipated to propel the market growth over the forecast period.
  • However, the side effects or complications associated with intragastric balloons may hamper the market growth over the forecast period.

Intragastric Balloon Industry Overview

The intragastric balloon market is moderately competitive with several major players. Some companies currently dominating the market are Obalon Therapeutics, Apollo Endosurgery Inc., Allurion Technologies Inc., Spatz3, ReShape Lifesciences, MEDSIL, Hélioscopie, and Silimed. Mergers and acquisitions, divestments, and new product developments and launches are the key strategies adopted by established market players.

Intragastric Balloon Market Leaders

  1. Apollo Endosurgery, Inc.

  2. Allurion Technologies Inc

  3. Spatz3

  4. ReShape Lifesciences

  5. Obalon Therapeutics

  6. *Disclaimer: Major Players sorted in no particular order
Intragastric Balloon Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Intragastric Balloon Market News

  • October 2022: Allurion received approval to launch its revolutionary gastric balloon technology in Brazil. The Allurion Balloon, known in Brazil as the Elipse Balloon, is the first and only intragastric weight-loss balloon that is routinely placed and removed without surgery, endoscopy, or anesthesia.
  • September 2022: Allurion launched its swallowable gastric balloon capsule for weight loss in India. Allurion launched a complete weight loss program in India that includes the Allurion Swallowable Capsule, the Allurion Virtual Care Suite, a remote patient monitoring solution powered by the Allurion Iris AI platform that includes the Allurion Mobile App, Connected Scale, and Health Tracker.

Intragastric Balloon Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Adoption of Minimally Invasive Treatment
    • 4.2.2 Increasing Prevalence of Obesity
  • 4.3 Market Restraints
    • 4.3.1 Side Effects or Complications Associated with Intragastric Balloons
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Type
    • 5.1.1 Single
    • 5.1.2 Dual
    • 5.1.3 Triple
  • 5.2 By Filling Material
    • 5.2.1 Gas Filled
    • 5.2.2 Saline Filled
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Rest of the World

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Obalon Therapeutics
    • 6.1.2 Apollo Endosurgery Inc.
    • 6.1.3 Allurion Technologies Inc.
    • 6.1.4 Spatz3
    • 6.1.5 ReShape Lifesciences
    • 6.1.6 Lexel Medical
    • 6.1.7 Endalis
    • 6.1.8 MEDSIL
    • 6.1.9 Hélioscopie
    • 6.1.10 Silimed
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Intragastric Balloon Industry Segmentation

An intragastric balloon, also known as a stomach balloon, is used for treating patients who are obese or overweight. These medical devices are kept inside the stomach to reduce weight. 

The intragastric balloon market is segmented by type (single, dual, and triple), filling material (gas-filled and saline-filled), end user (hospitals, ambulatory surgery centers, and other end users), and geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. 

The report offers the value (in USD) for the above segments.

By Type Single
Dual
Triple
By Filling Material Gas Filled
Saline Filled
By End User Hospitals
Ambulatory Surgical Centers
Others
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World
Need A Different Region or Segment?
Customize Now

Intragastric Balloon Market Research FAQs

What is the current Global Intragastric Balloon Market size?

The Global Intragastric Balloon Market is projected to register a CAGR of 9.1% during the forecast period (2025-2030)

Who are the key players in Global Intragastric Balloon Market?

Apollo Endosurgery, Inc., Allurion Technologies Inc, Spatz3, ReShape Lifesciences and Obalon Therapeutics are the major companies operating in the Global Intragastric Balloon Market.

Which is the fastest growing region in Global Intragastric Balloon Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Intragastric Balloon Market?

In 2025, the North America accounts for the largest market share in Global Intragastric Balloon Market.

What years does this Global Intragastric Balloon Market cover?

The report covers the Global Intragastric Balloon Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Intragastric Balloon Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Intragastric Balloon Industry Report

Statistics for the 2025 Intragastric Balloon market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Intragastric Balloon analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.